Tru Independence Asset Management 2’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,955
Closed -$684K 101
2021
Q4
$684K Sell
26,955
-17,207
-39% -$815K 0.36% 53
2021
Q3
$1.19M Buy
+44,162
New +$2.15M 0.84% 26
2021
Q1
Sell
-40,961
Closed -$1.17M 143
2020
Q4
$1.17M Buy
+40,961
New +$1.86M 0.99% 23

Other funds holding BME

Tru Independence Asset Management 2's BME Position: Q1 2022 in Review

Tru Independence Asset Management 2 sold out of BlackRock Health Sciences Trust (BME) in Q1 2022, closing a stake of 26,955 shares — an estimated $684K sold.

Tru Independence Asset Management 2 first reported a position in BME in Q4 2020 and held it in 3 quarters. The position peaked at $1.19M in Q3 2021. 58 funds tracked by Wall St. Rank hold BME as of Q1 2022.

  • Tru Independence Asset Management 2 reported no remaining BlackRock Health Sciences Trust position as of Q1 2022 after selling out during the quarter.
  • Tru Independence Asset Management 2 sold 26,955 BlackRock Health Sciences Trust shares in Q1 2022, an estimated $684K.
  • Tru Independence Asset Management 2 first reported a position in BlackRock Health Sciences Trust in Q4 2020 and held it in 3 quarters.
  • Tru Independence Asset Management 2's BlackRock Health Sciences Trust position peaked at $1.19M in Q3 2021.
  • 58 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2022.

Based on Tru Independence Asset Management 2's 13F filing for Q1 2022, filed 27 Apr 2022.